Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles

Yuanyuan Zhu, Wei Zhang, Jing Chen Department of Pharmacy, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital Affiliated with Qingdao University, Qingdao, Shandong Province, People’s Republic of ChinaCorrespondence: Jing Chen, Department of Pharmacy, Qingdao Hospital of Traditi...

Full description

Bibliographic Details
Main Authors: Zhu Y, Zhang W, Chen J
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/binary-nanodrug-delivery-system-designed-for-leukemia-therapy-aptamer--peer-reviewed-fulltext-article-DDDT
_version_ 1797958287302328320
author Zhu Y
Zhang W
Chen J
author_facet Zhu Y
Zhang W
Chen J
author_sort Zhu Y
collection DOAJ
description Yuanyuan Zhu, Wei Zhang, Jing Chen Department of Pharmacy, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital Affiliated with Qingdao University, Qingdao, Shandong Province, People’s Republic of ChinaCorrespondence: Jing Chen, Department of Pharmacy, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital Affiliated with Qingdao University, 4 Renmin Road, Qingdao, Shandong Province, 266000, People’s Republic of China, Email chenjingqdu@outlook.comObjective: This study aimed to develop a binary nanodrug-delivery system decorated with aptamers (APs) and transferrin (Tf) and loaded with daunorubicin (Drn) and luteolin (Lut) for the treatment of leukemia.Methods: Oligonucleotide AP- and Tf-contaiing ligands were designed and synthesized separately. AP-decorated Drn-loaded nanoparticles (AP-Drn NPs) and Tf-Lut NPs were prepared by self-assembly. An AP- and Tf-codecorated Drn- and Lut-coloaded nanodrug-delivery system (AP/Tf-Drn/Lut NPs) was prepared by self-assembly of AP-Drn NPs and Tf-Lut NPs. In vitro and in vivo efficiency of the system was evaluated on leukemia cell line and cell-bearing mouse model in comparison with single ligand–decorated, single drug–loaded and free-drug formulations.Results: AP/Tf-Drn/Lut NPs were spherical and nanosized (187.3± 5.3 nm) and loaded with about 85% of drugs. In vitro cytotoxicity of AP/Tf-Drn/Lut NPs was remarkably higher than single ligand–decorated ones. Double drug–loaded AP/Tf-Drn/Lut NPs exhibited higher tumor-cell inhibition than single drug–loaded ones, which showed a synergic effect of the two drugs. AP/Tf-Drn/Lut NPs achieved the most efficient antileukemic activity and absence of toxicity in vivo.Conclusion: The present study showed that AP/Tf-Drn/Lut NPs are a promising drug-delivery system for targeted treatment of leukemia, due to the synergic effect of the two drugs in this system. The limitations of this system include stability during large-scale production and application from bench to bedside.Keywords: acute myeloid leukemia, daunorubicin, luteolin, aptamer, transferrin, nanodrug-delivery system
first_indexed 2024-04-11T00:17:53Z
format Article
id doaj.art-bea196ee1ce84eff82d795c62a080b03
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-04-11T00:17:53Z
publishDate 2023-01-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-bea196ee1ce84eff82d795c62a080b032023-01-08T17:06:51ZengDove Medical PressDrug Design, Development and Therapy1177-88812023-01-01Volume 1711380846Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded NanoparticlesZhu YZhang WChen JYuanyuan Zhu, Wei Zhang, Jing Chen Department of Pharmacy, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital Affiliated with Qingdao University, Qingdao, Shandong Province, People’s Republic of ChinaCorrespondence: Jing Chen, Department of Pharmacy, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Hiser Hospital Affiliated with Qingdao University, 4 Renmin Road, Qingdao, Shandong Province, 266000, People’s Republic of China, Email chenjingqdu@outlook.comObjective: This study aimed to develop a binary nanodrug-delivery system decorated with aptamers (APs) and transferrin (Tf) and loaded with daunorubicin (Drn) and luteolin (Lut) for the treatment of leukemia.Methods: Oligonucleotide AP- and Tf-contaiing ligands were designed and synthesized separately. AP-decorated Drn-loaded nanoparticles (AP-Drn NPs) and Tf-Lut NPs were prepared by self-assembly. An AP- and Tf-codecorated Drn- and Lut-coloaded nanodrug-delivery system (AP/Tf-Drn/Lut NPs) was prepared by self-assembly of AP-Drn NPs and Tf-Lut NPs. In vitro and in vivo efficiency of the system was evaluated on leukemia cell line and cell-bearing mouse model in comparison with single ligand–decorated, single drug–loaded and free-drug formulations.Results: AP/Tf-Drn/Lut NPs were spherical and nanosized (187.3± 5.3 nm) and loaded with about 85% of drugs. In vitro cytotoxicity of AP/Tf-Drn/Lut NPs was remarkably higher than single ligand–decorated ones. Double drug–loaded AP/Tf-Drn/Lut NPs exhibited higher tumor-cell inhibition than single drug–loaded ones, which showed a synergic effect of the two drugs. AP/Tf-Drn/Lut NPs achieved the most efficient antileukemic activity and absence of toxicity in vivo.Conclusion: The present study showed that AP/Tf-Drn/Lut NPs are a promising drug-delivery system for targeted treatment of leukemia, due to the synergic effect of the two drugs in this system. The limitations of this system include stability during large-scale production and application from bench to bedside.Keywords: acute myeloid leukemia, daunorubicin, luteolin, aptamer, transferrin, nanodrug-delivery systemhttps://www.dovepress.com/binary-nanodrug-delivery-system-designed-for-leukemia-therapy-aptamer--peer-reviewed-fulltext-article-DDDTacute myeloid leukemiadaunorubicinluteolinaptamertransferrinnano drug delivery system
spellingShingle Zhu Y
Zhang W
Chen J
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
Drug Design, Development and Therapy
acute myeloid leukemia
daunorubicin
luteolin
aptamer
transferrin
nano drug delivery system
title Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
title_full Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
title_fullStr Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
title_full_unstemmed Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
title_short Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles
title_sort binary nanodrug delivery system designed for leukemia therapy aptamer and transferrin codecorated daunorubicin and luteolin coloaded nanoparticles
topic acute myeloid leukemia
daunorubicin
luteolin
aptamer
transferrin
nano drug delivery system
url https://www.dovepress.com/binary-nanodrug-delivery-system-designed-for-leukemia-therapy-aptamer--peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT zhuy binarynanodrugdeliverysystemdesignedforleukemiatherapyaptamerandtransferrincodecorateddaunorubicinandluteolincoloadednanoparticles
AT zhangw binarynanodrugdeliverysystemdesignedforleukemiatherapyaptamerandtransferrincodecorateddaunorubicinandluteolincoloadednanoparticles
AT chenj binarynanodrugdeliverysystemdesignedforleukemiatherapyaptamerandtransferrincodecorateddaunorubicinandluteolincoloadednanoparticles